VIANEX expands by co-operating with BRISTOL-MYERS SQUIBB

vianexFrom 1 April 2015, VIAN SA, a company in the VIANEX Group, will undertake the distribution and marketing of the Depon range of analgesics/antipyretics. Depon is the Νο1 product in the category of non-narcotic analgesics* with proven results for 43 years.All forms of Depon have the full confidence of health professionals in both the medical and pharmaceutical communities.VIAN SA, a company in the VIANEX SA group, celebrates 20 years of dynamic growth this year and has a very strong presence with the nationwide network of pharmacies. It supports the presence of very many famous and successful products in pharmacies. Additionally, the majority of our products are supported by medical information.

Mr Dimitris Giannakopoulos, Vice President and Deputy CEO of the VIANEX Group stated “It is a great joy and honour that our cooperation with Bristol-Myers Squibb coincides with the 20th anniversary of the founding of VIAN. I am sure that this cooperation will be highly successful.”Mr. Emmanuel Lorge, CEO of Bristol-Myers Squibb Greece said: “This cooperation with Vian-Vianex contributes to Greek entrepreneurship and the Greek economy, and also to the growth of both companies and the exchange of know-how between them. We are also certain that this will be a highly successful partnership.” VIAN and the VIANEX Group actively support Greek Pharmacies.

*IMS Data